Literature DB >> 33501605

Aggresomes predict poor outcomes and implicate proteostasis in the pathogenesis of pediatric choroid plexus tumors.

Nada Amer1, Hala Taha2,3, Dina Hesham1, Nouran Al-Shehaby1, Amal Mosaab1, Mohamed Soudy4, Aya Osama4, Noura Mahmoud5, Moatasem Elayadi5,6, Ayda Youssef7,8, Mohamed Elbeltagy9,10, Mohamed Saad Zaghloul11,12, Sameh Magdeldin4,13, Ahmed A Sayed14,15, Shahenda El-Naggar16.   

Abstract

PURPOSE: Protein misfolding and aggregation result in proteotoxic stress and underlie the pathogenesis of many diseases. To overcome proteotoxicity, cells compartmentalize misfolded and aggregated proteins in different inclusion bodies. The aggresome is a paranuclear inclusion body that functions as a storage compartment for misfolded proteins. Choroid plexus tumors (CPTs) are rare neoplasms comprised of three pathological subgroups. The underlying mechanisms of their pathogenesis remain unclear. This study aims to elucidate the prognostic role and the biological effects of aggresomes in pediatric CPTs.
METHODS: We examined the presence of aggresomes in 42 patient-derived tumor tissues by immunohistochemistry and we identified their impact on patients' outcomes. We then investigated the proteogenomics signature associated with aggresomes using whole-genome DNA methylation and proteomic analysis to define their role in the pathogenesis of pediatric CPTs.
RESULTS: Aggresomes were detected in 64.2% of samples and were distributed among different pathological and molecular subgroups. The presence of aggresomes with different percentages was correlated with patients' outcomes. The ≥ 25% cutoff had the most significant impact on overall and event-free survival (p-value < 0.001) compared to the pathological and the molecular stratifications.
CONCLUSIONS: These results support the role of aggresome as a novel prognostic molecular marker for pediatric CPTs that was comparable to the molecular classification in segregating samples into two distinct subgroups, and to the pathological stratification in the prediction of patients' outcomes. Moreover, the proteogenomic signature of CPTs displayed altered protein homeostasis, manifested by enrichment in processes related to protein quality control.

Entities:  

Keywords:  Aggresomes; Choroid plexus; Prognosis; Proteogenomics; Proteostasis

Year:  2021        PMID: 33501605      PMCID: PMC7910251          DOI: 10.1007/s11060-020-03694-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  48 in total

1.  Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics.

Authors:  Frank Dieterle; Alfred Ross; Götz Schlotterbeck; Hans Senn
Journal:  Anal Chem       Date:  2006-07-01       Impact factor: 6.986

2.  pcaMethods--a bioconductor package providing PCA methods for incomplete data.

Authors:  Wolfram Stacklies; Henning Redestig; Matthias Scholz; Dirk Walther; Joachim Selbig
Journal:  Bioinformatics       Date:  2007-03-07       Impact factor: 6.937

Review 3.  Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies.

Authors:  Erol E Gulcicek; Christopher M Colangelo; Walter McMurray; Kathryn Stone; Kenneth Williams; Terence Wu; Hongyu Zhao; Heidi Spratt; Alexander Kurosky; Baolin Wu
Journal:  Curr Protoc Bioinformatics       Date:  2005-07

4.  GREAT improves functional interpretation of cis-regulatory regions.

Authors:  Cory Y McLean; Dave Bristor; Michael Hiller; Shoa L Clarke; Bruce T Schaar; Craig B Lowe; Aaron M Wenger; Gill Bejerano
Journal:  Nat Biotechnol       Date:  2010-05-02       Impact factor: 54.908

5.  Molecular properties of Zic proteins as transcriptional regulators and their relationship to GLI proteins.

Authors:  K Mizugishi; J Aruga; K Nakata; K Mikoshiba
Journal:  J Biol Chem       Date:  2000-10-26       Impact factor: 5.157

Review 6.  Sonic Hedgehog in cancer stem cells: a novel link with autophagy.

Authors:  Luis A Milla; Claudia N González-Ramírez; Verónica Palma
Journal:  Biol Res       Date:  2012       Impact factor: 5.612

7.  LC3A Silencing Hinders Aggresome Vimentin Cage Clearance in Primary Choroid Plexus Carcinoma.

Authors:  Marwa Nassar; Heba Samaha; Myret Ghabriel; Maha Yehia; Hala Taha; Sherin Salem; Khaled Shaaban; Mariam Omar; Nabil Ahmed; Shahenda El-Naggar
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

8.  DNA methylation-based classification of central nervous system tumours.

Authors:  David Capper; David T W Jones; Martin Sill; Volker Hovestadt; Daniel Schrimpf; Dominik Sturm; Christian Koelsche; Felix Sahm; Lukas Chavez; David E Reuss; Annekathrin Kratz; Annika K Wefers; Kristin Huang; Kristian W Pajtler; Leonille Schweizer; Damian Stichel; Adriana Olar; Nils W Engel; Kerstin Lindenberg; Patrick N Harter; Anne K Braczynski; Karl H Plate; Hildegard Dohmen; Boyan K Garvalov; Roland Coras; Annett Hölsken; Ekkehard Hewer; Melanie Bewerunge-Hudler; Matthias Schick; Roger Fischer; Rudi Beschorner; Jens Schittenhelm; Ori Staszewski; Khalida Wani; Pascale Varlet; Melanie Pages; Petra Temming; Dietmar Lohmann; Florian Selt; Hendrik Witt; Till Milde; Olaf Witt; Eleonora Aronica; Felice Giangaspero; Elisabeth Rushing; Wolfram Scheurlen; Christoph Geisenberger; Fausto J Rodriguez; Albert Becker; Matthias Preusser; Christine Haberler; Rolf Bjerkvig; Jane Cryan; Michael Farrell; Martina Deckert; Jürgen Hench; Stephan Frank; Jonathan Serrano; Kasthuri Kannan; Aristotelis Tsirigos; Wolfgang Brück; Silvia Hofer; Stefanie Brehmer; Marcel Seiz-Rosenhagen; Daniel Hänggi; Volkmar Hans; Stephanie Rozsnoki; Jordan R Hansford; Patricia Kohlhof; Bjarne W Kristensen; Matt Lechner; Beatriz Lopes; Christian Mawrin; Ralf Ketter; Andreas Kulozik; Ziad Khatib; Frank Heppner; Arend Koch; Anne Jouvet; Catherine Keohane; Helmut Mühleisen; Wolf Mueller; Ute Pohl; Marco Prinz; Axel Benner; Marc Zapatka; Nicholas G Gottardo; Pablo Hernáiz Driever; Christof M Kramm; Hermann L Müller; Stefan Rutkowski; Katja von Hoff; Michael C Frühwald; Astrid Gnekow; Gudrun Fleischhack; Stephan Tippelt; Gabriele Calaminus; Camelia-Maria Monoranu; Arie Perry; Chris Jones; Thomas S Jacques; Bernhard Radlwimmer; Marco Gessi; Torsten Pietsch; Johannes Schramm; Gabriele Schackert; Manfred Westphal; Guido Reifenberger; Pieter Wesseling; Michael Weller; Vincent Peter Collins; Ingmar Blümcke; Martin Bendszus; Jürgen Debus; Annie Huang; Nada Jabado; Paul A Northcott; Werner Paulus; Amar Gajjar; Giles W Robinson; Michael D Taylor; Zane Jaunmuktane; Marina Ryzhova; Michael Platten; Andreas Unterberg; Wolfgang Wick; Matthias A Karajannis; Michel Mittelbronn; Till Acker; Christian Hartmann; Kenneth Aldape; Ulrich Schüller; Rolf Buslei; Peter Lichter; Marcel Kool; Christel Herold-Mende; David W Ellison; Martin Hasselblatt; Matija Snuderl; Sebastian Brandner; Andrey Korshunov; Andreas von Deimling; Stefan M Pfister
Journal:  Nature       Date:  2018-03-14       Impact factor: 49.962

9.  Sonic Hedgehog promotes proliferation of Notch-dependent monociliated choroid plexus tumour cells.

Authors:  Li Li; Katie B Grausam; Jun Wang; Melody P Lun; Jasmin Ohli; Hart G W Lidov; Monica L Calicchio; Erliang Zeng; Jeffrey L Salisbury; Robert J Wechsler-Reya; Maria K Lehtinen; Ulrich Schüller; Haotian Zhao
Journal:  Nat Cell Biol       Date:  2016-03-21       Impact factor: 28.824

10.  Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma.

Authors:  Albert Cornelius; Jessica Foley; Jeffrey Bond; Abhinav B Nagulapally; Julie Steinbrecher; William P D Hendricks; Maria Rich; Sangeeta Yendrembam; Genevieve Bergendahl; Jeffrey M Trent; Giselle S Sholler
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.